Is the duration of dual antiplatelet therapy (DAPT) excessive in post-angioplasty in chronic coronary syndrome? Data from the France-PCI registry (2014–2019)
A. Mezier, Pascal Motreff, J. M. Clerc, O. Bar et autres
Background: while the duration of dual antiplatelet therapy (DAPT) following coronary angioplasty for chronic coronary syndrome (CCS) recommended by the European Society of Cardiology has decreased over the last decade, little is known about the adherence to those guidelines in clinical practice …
fr (code pays fourni par la source)
6 citations
Frontiers in Cardiovascular Medicine